|
GLUD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19089976663633E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.77900000011932E-07 |
| Normal-vs-Stage2 |
1.35069733175897E-11 |
| Normal-vs-Stage3 |
7.36770000564491E-09 |
| Normal-vs-Stage4 |
5.71920000247417E-08 |
| Stage1-vs-Stage2 |
7.79310000000866E-05 |
| Stage1-vs-Stage3 |
1.392770E-01 |
| Stage1-vs-Stage4 |
1.158840E-01 |
| Stage2-vs-Stage3 |
2.062100E-02 |
| Stage2-vs-Stage4 |
1.119960E-01 |
| Stage3-vs-Stage4 |
6.525600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.47220030505468E-10 |
| Normal-vs-AfricanAmerican |
1.403770E-03 |
| Normal-vs-Asian |
1.138740E-03 |
| Caucasian-vs-AfricanAmerican |
7.550600E-01 |
| Caucasian-vs-Asian |
2.394800E-01 |
| AfricanAmerican-vs-Asian |
6.746800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94799999997386E-06 |
| Normal-vs-Female |
8.97999452575959E-11 |
| Male-vs-Female |
2.037600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.206300E-04 |
| Normal-vs-Age(41-60Yrs) |
4.93769469755989E-11 |
| Normal-vs-Age(61-80Yrs) |
1.07770015134179E-10 |
| Normal-vs-Age(81-100Yrs) |
1.886210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.701570E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.06209999999274E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.869400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.172200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.358000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.050000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.563200E-01 |
| Classical-VS-Follicular |
3.40409922472418E-11 |
| Classical-VS-Other |
5.921200E-01 |
| Classical-VS-Normal |
1.00069999997565E-06 |
| Tall-VS-Follicular |
1.000480E-04 |
| Tall-VS-Other |
6.250600E-01 |
| Tall-VS-Normal |
3.751700E-04 |
| Follicular-VS-Other |
1.233420E-01 |
| Follicular-VS-Normal |
3.49609230454462E-13 |
| Other-VS-Normal |
1.906020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.25739435425021E-13 |
| Normal-vs-N1 |
2.72800000000739E-06 |
| N0-vs-N1 |
2.022600E-01 |
|
|
